Home' Australian Pharmacist : Australian Pharmacist October 2014 Contents Aspen Pharma Pty Ltd
ABN: 88 004 118 594
34-36 Chandos Street, St Leonards NSW 2065
Phone: +61 2 8436 8300 ~ Fax: +61 2 9901 3540
Chlorsig Drops Supply Update
As you may be aware, there have been supply issues with Chlorsig (chloramphenicol) eye drops. Aspen has been
working with the manufacturer in Germany to resolve these issues.
We are now pleased to advise these have been fxed and as a result we have just supplied 400,000 units to the
Pharmacy market via your wholesaler. This should clear most of your back orders. We would like to thank you for your
patience during this time.
The next delivery of Chlorsig eye drops is imminent and will then be available from your wholesaler upon arrival.
Thereafter, Aspen expects no further supply issues for the foreseeable future and plan to work with Pharmacy to
provide positive patient outcomes.
Your patients can once again beneft from Australia’s number one selling brand for bacterial conjunctivitis.1,2
The Chlorsig brand has over 40 years1 of clinical experience in Australia. Aspen is dedicated to supporting pharmacy
with this brand via a range of materials, including:
• Printed CMI tear off pads
• Chlorsig stationery
• Educational material on the causes and treatments of red eye that commonly present to pharmacists
Chlorsig drops will continue to be supplied in a single opaque plastic bottle designed to protect
the contents from light3.
Orders for Chlorsig drops should be placed as per usual with your wholesaler.
In store support materials are available from your local Lennon Sales Representative.
Contact the Aspen Contact Centre on 1300 659 646 (option 3) if you are unsure
of their contact details.
Thank you for your continued support of Chlorsig.
Senior Brand Manager
Please review Product Information before recommending. Full Product Information is available
on request from Aspen Pharma or via www.aspenpharma.com.au
Minimum Product Information: Chlorsig® (chloramphenicol) Indications: For the treatment of bacterial conjunctivitis. Other superficial ocular infections caused by chloramphenicol-sensitive
organisms under medical supervision only. Contraindications: Hypersensitivity to any excipients and or/toxic reaction to the drug. Precautions: Bone marrow hypoplasia, including aplastic anaemia and
death, has been rarely reported following local application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agents would be expected to provide effective treatment.
Ophthalmic agents may retard corneal wound healing. Eye pain/injury, reduced or blurred vision, severe ocular infections, contact lenses, dry eye syndrome, glaucoma, concomitant use of other ocular
medications, eye surgery or laser within the last 6 months, pregnancy (Cat A), lactation. See full PI. Adverse Reactions: Blood dyscrasias; local irritation
(itching/burning), angioneurotic oedema; anaphylaxis, urticaria, fever, vesicular, maculopapular dermatitis. Dosage and Administration: Adults and children
(2 years and over): Instil 1 or 2 drops in the affected eye(s) every two to six hours for up to 5 days. Chlorsig is not recommended for children under 2 years
except on medical advice. See full PI. (PI last amended Oct 2010). ® Chlorsig is a registered trademark of Aspen. References: 1. Australian Pharmaceutical
Index IMS Health Australia Pty Ltd. 2014. 2. Chlorsig Product Information (Oct, 2010). 3. Data on file. *Aspen Australia is comprised of Aspen Asia Pacific Pty
Ltd (ABN 75 146 444 484) and its subsidiaries, including Aspen Pharmacare Australia Pty Ltd (ABN 51 096 236 985), Aspen Pharma Pty Ltd (ABN 88 004
118 594), Aspen Nutritionals Australia Pty Limited (ACN 160607509), Orphan Holdings Pty Ltd (ABN 50 115 816 209), Orphan Australia Pty Ltd (ABN 11 067
189 342) and Arrow Pharmaceuticals Pty Ltd (ABN 17 003 144 170). Date prepared, September 2014 ASP620. TAPH0023/AP
Links Archive Australian Pharmacist September 2014 Australian Pharmacist November 2014 Navigation Previous Page Next Page